There will be folks out there who think a delay in finalising the trial protocol is a setback.
They still need to revise it and then go back to the FDA for approval. But I think we knew this already so its not actually news.
- Forums
- ASX - By Stock
- PNV
- Ann: FDA feedback on Pivotal Protocol
PNV
polynovo limited
Add to My Watchlist
2.46%
!
$1.25

Ann: FDA feedback on Pivotal Protocol, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.25 |
Change
0.030(2.46%) |
Mkt cap ! $865.2M |
Open | High | Low | Value | Volume |
$1.22 | $1.26 | $1.20 | $1.249M | 1.013M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 87356 | $1.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 3120 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 22436 | 1.250 |
25 | 89884 | 1.245 |
15 | 83534 | 1.240 |
17 | 83865 | 1.235 |
11 | 20117 | 1.230 |
Price($) | Vol. | No. |
---|---|---|
1.255 | 13564 | 17 |
1.260 | 57115 | 19 |
1.265 | 372011 | 13 |
1.270 | 197835 | 12 |
1.275 | 14688 | 2 |
Last trade - 13.18pm 18/07/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |